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Sulfonamides are synthetic chemotherapeutic agents that work as competitive inhibitors
of the di-hydro-pteroate synthase (DHPS) enzyme, encoded by the folP gene.
Resistance to sulfonamides is widespread in the clinical setting and predominantly
mediated by plasmid- and integron-borne sul1-3 genes encoding mutant DHPS
enzymes that do not bind sulfonamides. In spite of their clinical importance, the
genetic origin of sul1-3 genes remains unknown. Here we analyze sul genes and their
genetic neighborhoods to uncover sul signature elements that enable the elucidation
of their genetic origin. We identify a protein sequence Sul motif associated with sul-
encoded proteins, as well as consistent association of a phosphoglucosamine mutase
gene (glmM) with the sul2 gene. We identify chromosomal folP genes bearing these
genetic markers in two bacterial families: the Rhodobiaceae and the Leptospiraceae.
Bayesian phylogenetic inference of FolP/Sul and GlmM protein sequences clearly
establishes that sul1-2 and sul3 genes originated as a mobilization of folP genes
present in, respectively, the Rhodobiaceae and the Leptospiraceae, and indicate that
the Rhodobiaceae folP gene was transferred from the Leptospiraceae. Analysis of
%GC content in folP/sul gene sequences supports the phylogenetic inference results
and indicates that the emergence of the Sul motif in chromosomally encoded FolP
proteins is ancient and considerably predates the clinical introduction of sulfonamides.
In vitro assays reveal that both the Rhodobiaceae and the Leptospiraceae, but not
other related chromosomally encoded FolP proteins confer resistance in a sulfonamide-
sensitive Escherichia coli background, indicating that the Sul motif is associated with
sulfonamide resistance. Given the absence of any known natural sulfonamides targeting
DHPS, these results provide a novel perspective on the emergence of resistance to
synthetic chemotherapeutic agents, whereby preexisting resistant variants in the vast
bacterial pangenome may be rapidly selected for and disseminated upon the clinical
introduction of novel chemotherapeuticals.
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INTRODUCTION
Antibiotic resistance is a pressing problem in modern healthcare
(Carlet et al., 2014; Rossolini et al., 2014). Bacterial cells
present several mechanisms to cope with exposure to antibiotics
or chemotherapeutic agents, which may be acquired through
mutation or, most frequently, via lateral gene transfer on
mobile genetic elements (Davies and Davies, 2010). These
mechanisms include modification of the antimicrobial target,
degradation or chemical modification of the antimicrobial
molecule, targeted reduction of antimicrobial uptake, active
export of the antimicrobial through efflux pumps and use of
alternate pathways and enzymes (Davies and Davies, 2010).
It is widely accepted that many antibiotic resistance genes
present today in pathogenic bacteria originated from homologs
evolved over eons in either the microbes that naturally produce
the antibiotics or their natural competitors (Aminov and
Mackie, 2007). When coupled with the high plasticity of
bacterial genomes and their co-existence with a large variety
of genetic mobile elements, the availability of a readily evolved
pool of antibiotic resistance genes set the stage for the rapid
proliferation of multi-resistant strains in the clinical setting
shortly after the commercial introduction of antibiotics (Aminov
and Mackie, 2007). In contrast, the origins of resistance against
chemotherapeutic agents are harder to pinpoint. Since these were
designed in vitro, it seems unlikely that a large pool of genes
conferring resistance to chemotherapeutic agents existed before
their introduction. After their discovery in the 1960’s, resistance
to quinolones was initially rare and limited to chromosomal
mutations in DNA gyrase, topoisomerase IV or efflux pumps
(Hooper, 1999). However, in the early 2000’s plasmid-borne qnr
genes were first detected and spread rapidly to clinical pathogens.
Qnr is a member of the pentapeptide repeat family and was
shown to confer resistance by binding to DNA gyrase and
limiting the effect of quinolone drugs. The origin of plasmid-
borne qnr genes has been traced to environmental homologs
and these are thought to have derived from genes originally
targeting antibiotics, such as microcin B17 (Tran and Jacoby,
2002).
Aryl sulfonamides are synthetic antibacterial compounds
presenting a structure similar to para-amino benzoic acid
(PABA), and containing a sulfonamide group linked to an
aromatic group. Commonly referred to as sulfonamides or sulfa
drugs due to their clinical relevance, synthetic aryl sulfonamides
function as competitive inhibitors of the di-hydro-pteroate
synthase (DHPS) enzyme, encoded in bacteria by the folP gene
(Sköld, 2000). DHPS participates in folate synthesis using PABA
as a substrate, and the competitive inhibition of DHPS by
sulfonamides results in growth arrest (Mitsuhashi, 1993; Sköld,
2000). Experiments in mice in the 1930’s demonstrated the
effectiveness of sulfonamide against bacteria, and sulfonamide
became the first antibacterial chemotherapeutic to be used
systemically (Domagk, 1935; Aminov, 2010). It remained in
use throughout World War II, but by the end of the 1940’s
resistant strains started to emerge and sulfonamides were rapidly
displaced in favor of the newly discovered antibiotics (Sköld,
2000; Davenport, 2012).
Resistance to sulfonamide through increased production of
PABA was reported in the early 1940’s (Landy et al., 1943), but the
most commonly reported mechanism of sulfonamide resistance
are mutations to the chromosomal folP gene (Huovinen et al.,
1995; Sköld, 2000). Mutations to the chromosomal folP gene
have been shown to provide varying degrees of trade-off
between resistance and efficient folate synthesis, decreasing
DHPS affinity for sulfonamide while maintaining or increasing its
affinity for PABA (Sköld, 2000). These mutations have occurred
independently in multiple bacterial genera and target multiple
conserved areas of the DHPS protein (Sköld, 2000). However,
similar mutational profiles, such as two-amino acid insertions in
Neisseria meningitidis and Streptococcus pneumoniae, have been
reported (Rådström et al., 1992; Haasum et al., 2001), and in both
these genera there is evidence of extensive recombination within
folP genes (Fermer et al., 1995; Swedberg et al., 1998).
In spite of the multiple instances of chromosomal folP
resistant variants, clinical resistance to sulfonamides is
predominantly plasmid-borne and mediated by sul genes
encoding alternative sulfonamide-resistant DHPS enzymes
(Sköld, 2000). Four different sul genes have been described to
date, with sul1 and sul2 being the predominant forms in clinical
isolates (Rådström et al., 1991). The sul1 gene is typically found in
class 1 integrons and linked to other resistance genes (Rådström
et al., 1991), whereas sul2 is usually associated to non-conjugative
plasmids of the IncQ group (Enne et al., 2001) and to large
transmissible plasmids like pBP1 (Treeck et al., 1981). The
sul3 gene was characterized in the Escherichia coli conjugative
plasmid pVP440. It was shown to be flanked by two copies of
the insertion element IS151/26 and to be widespread in E. coli
isolates from pigs in Switzerland (Perreten and Boerlin, 2003).
Recently, a sul4 gene was identified in a systematic prospection of
class 1 integron-borne genes in Indian river sediments, but this
sul variant has not yet been detected in clinical isolates. Genomic
context analyses revealed that the sul4 gene had been recently
mobilized and phylogenetic inference pinpointed its putative
origin as part of the folate synthesis cluster in the Chloroflexi
phylum (Razavi et al., 2017).
Despite the importance of sulfonamides in human and
animal therapy, the putative origin of the three sul genes that
account for the vast majority of reported clinical resistance to
sulfonamide remains to be elucidated. In this work we leverage
comparative genomics, phylogenetic analysis and in vitro
determination of minimal inhibitory concentrations (MIC) of
sulfamethoxazole to unravel the origin of the sul1, sul2, and
sul3 genes. Our analysis indicates that chromosomally encoded
folP genes conferring resistance to sulfonamide originated in
members of the Leptospiraceae family and were transferred to the
Alphaproteobacteria Rhodobiaceae family more than 500 million
years ago. These isolated sources of chromosomally encoded
sulfonamide-resistant DHPS were mobilized independently,
leading to the broadly disseminated sul1, sul2, and sul3 resistance
genes. Our results hence indicate that resistance to synthetic
chemotherapeutic agents may be available in the form of
chromosomally encoded variants among the extremely diverse
bacterial domain, and can be rapidly disseminated upon the
release of novel synthetic drugs.
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MATERIALS AND METHODS
Data Collection
FolP, GlmM, and Sul1-3 homologs were identified in complete
GenBank sequences (GenBank, RRID:SCR_002760) through
BLASTP (BLASTP, RRID:SCR_001010) (Altschul et al.,
1997) using the E. coli FolP (WP_000764731) and GlmM
(WP_000071134) proteins as the query. Putative homologs
were detected as BLASTP hits passing stringent e-value
(<1e−20) and query coverage (75%) thresholds. FolP and
GlmM chromosomally encoded proteins were identified on a
representative genome of all bacterial orders with complete
genome assemblies on RefSeq (RefSeq, RRID:SCR_003496), of
each bacterial family for the Proteobacteria, of any bacterial
species where chromosomally encoded sulfonamide resistance
mutants had been reported, and on all available complete
genomes for clades of interest (Rhodobiaceae, Spirochaetes, and
Chlamydiae) (Supplementary Table S1). All protein coding gene
sequences for these genomes were downloaded for %GC analysis.
Sul proteins encoded by mobile sul genes were identified on
complete plasmid, transposon, and integron GenBank sequences
(GenBank, RRID:SCR_002760).
Identification and Visualization of
Sul-Like Signatures in FolP Sequences
To identify sequence motifs associated with Sul proteins,
we performed a CLUSTALW alignment (Clustal Omega,
RRID:SCR_001591) using a non-redundant (<99% identity)
subset of the Sul1-3 homologous sequences detected previously
and FolP sequence sampled from each bacterial clade. Following
visual inspection of the resulting alignment, a Sul-like motif
conserved in several chromosomally encoded FolP proteins was
visualized using iceLogo (iceLogo, RRID:SCR_012137) (Colaert
et al., 2009) and a consensus motif was derived and encoded
into a PROSITE-format pattern (PROSITE, RRID:SCR_003457).
The inferred PROSITE pattern was used to seed a Pattern
Hit Initiated BLAST (NCBI PHI-BLAST; RRID:SCR_004870)
search against the NCBI non-redundant Protein database
(Protein, RRID:SCR_003257) using as a query the protein
sequences of Sul1-3 reported in the literature (WP_001336346,
WP_010890159, and WP_000034420) and conservative e-value
(<1e−20) and query coverage (75%) limits. Only chromosomal
hits with the identified signature characteristic of sul gene
products were retained for further analysis.
Multiple Sequence Alignment and
Phylogenetic Inference
For phylogenetic inference, multiple sequence alignments
of identified FolP/Sul1-3 and GlmM homologous sequences
were performed with CLUSTALW (Clustal Omega,
RRID:SCR_001591) (Thompson et al., 1994) using variable
(5, 10, and 25) gap opening penalties. These alignments
were then integrated with local LALIGN alignments with
T-COFFEE (T-Coffee, RRID:SCR_011818) (Notredame et al.,
2000), and the resulting alignment was trimmed using the
“less stringent selection” parameters of the Gblocks online
service (Castresana, 2000; Dereeper et al., 2008). Bayesian
phylogenetic inference on trimmed alignments was performed
with MrBayes (MrBayes, RRID:SCR_012067) (Ronquist and
Huelsenbeck, 2003). Four Metropolis-Coupled Markov Chain
Monte Carlo runs with four independent chains were carried out
for 30,000,000 generations, and the resulting consensus tree was
plotted with FigTree (FigTree, RRID:SCR_008515).
DNA Sequence Analyses
Analysis of %GC in synonymous and non-synonymous
patterns and Ka/Ks divergence were performed according to
the Nei–Gojobori computation method (Nei and Gojobori,
1986) and the standalone PAL2NAL program for codon-based
alignments (Suyama et al., 2006), using custom Python scripts
for pipelining. Analyses of %GC content were performed on
all sampled bacterial genomes, computing genome-wide %GC
statistics and comparing them to folP estimates. Analyses of
Ka/Ks divergence were performed on pair-wise alignments
of the N- and C-terminal ends of the glmM gene sequence
of all sampled bacterial groups. One-sided Mann–Whitney
U-tests were performed using GraphPad Prism (GraphPad,
RRID:SCR_002798) to determine whether differences between
folP and chromosomal %GC content were significantly different
in the presence and absence of Sul-like signature motifs, and
whether the N- and C-terminal regions presented different
mutational profiles. The scripts used for the analysis are
available at the GitHub ErillLab repository. Nucleotide sequence
identities percentages were computed on gapless positions of
PAL2NAL codon-based alignments using a custom Python
script. Amelioration times were estimated using the Ameliorator
program (Lawrence and Ochman, 1997) under different
selection modes. Ka and Ks values were estimated from
pairwise alignments of orthologs between the Parvibaculum
lavamentivorans and Leptospira interrogans genomes as
determined by the OMA Orthology database (OMA Orthology
database, RRID:SCR_016425) (Altenhoff et al., 2018) and species
divergence times were inferred from published molecular clock
phylogenies (Battistuzzi et al., 2004).
Cloning, Transformation and
Complementation of the folP Gene for
Broth Microdilution Assays
The L. interrogans serovar Lai str. 56601 folP and Chlamydia
trachomatis D/UW-3/CX folKP gene were synthesized and
adapted to E. coli codon usage at ATG:biosynthetics GmbH,
Germany; whereas P. lavamentivorans DS-1 (DSMZ 13023) and
Rhodobacter sphaeroides 2.4.1 (gently provided by Professor
S. Kaplan; Health Science Center. University of Texas) folP
genes were amplified from genomic DNA. The sul2 gene was
amplified from the RSF1010 plasmid (Kushner, 1978; Honda
et al., 1991) and used as a positive control. The folP/sul genes
were amplified using suitable primers (Supplementary Table
S2), purified PCR products were then digested with NdeI
and BamHI (New England Biolabs, RRID:SCR_013517) and
cloned into a dephosphorylated pUA1108 vector (Mayola et al.,
2014), previously cut with the same restriction enzymes. The
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ligation was introduced by transformation into competent
E. coli DH5α cells and recombinant plasmids were extracted
with the NZYMiniprep kit (NZYTech, RRID:SCR_016772),
sequenced (Macrogen, RRID:SCR_014454) and introduced by
transformation in competent E. coli K-12 (CGSC 5073) (CGSC,
RRID:SCR_002303). Susceptibility to sulfamethoxazole (Sigma-
Aldrich, RRID:SCR_008988) for the strains containing the
folP/sul genes was determined using broth microdilution tests
in Mueller-Hinton broth (MH) with half serial dilutions
of sulfamethoxazole ranging from 512 to 0.125 mg/L,
following the CLSI guidelines (Clinical and Laboratory
Standards Institute, 2003). Colonies were grown on Luria-
Bertani (LB) agar for 18 h and then suspended in sterile
0.9% NaCl solution to a McFarland 0.5 turbidity level.
These suspensions were diluted at 10−2 in Mueller-Hinton
(MH) broth, and 50 µl (5.104 cells) were inoculated onto
microtiter plates containing 50 µl of MH broth supplemented
with 1024–0.250 mg/L of sulfamethoxazole. To determine
growth, absorbance at 550 nm was measured after 24 h
incubation at 37◦C (Sunrise plate reader; Tecan Life Sciences,
RRID:SCR_016771).
RESULTS
Identification of Putative Chromosomal
Origins for sul1-3 Genes
To identify putative chromosomal homologs of sul1-3 genes,
we performed a multiple sequence alignment including any
protein sequences with at most 90% similarity to those
encoded by sul1-3 genes reported in the literature and by
chromosomal folP genes from a representative of each bacterial
order. Inspection of the resulting alignment (Figure 1A and
Supplementary Data 1) revealed the presence of a two-
amino acid insertion in proteins encoded by sul1-3 genes
that is not present in those encoded by sul4 or the analyzed
chromosomal folP genes. This two-amino acid insertion is
located in a conserved region of the FolP protein (residues
R171-N211 of the E. coli FolP protein [WP_000764731]) that
presents other signature changes in sul-encoded proteins with
respect to chromosomally encoded FolP proteins (Figures 1A,B
and Supplementary Data 1) (Rådström and Swedberg, 1988;
Morgan et al., 2011). We derived a PROSITE-format pattern
(PROSITE, RRID:SCR_003457) (Supplementary Data 2) of
the identified Sul motif to seed a Pattern Hit Initiated
BLAST (NCBI PHI-BLAST; RRID:SCR_004870) search against
the NCBI non-redundant (NR) protein database (NCBI,
RRID:SCR_006472). This search identified several proteins
encoded by Rhodobiaceae family members that presented a
similar insertion pattern. BLASTP (BLASTP, RRID:AB_141607)
searches with these Rhodobiaceae FolP sequences matched
proteins in several members of the Leptospiraceae and the
Chlamydiae. However, analysis of the resulting multiple sequence
alignment showed that only the Leptospiraceae FolP protein
sequences displayed the identified two-amino acid insertion
pattern (Supplementary Data 3). Heretofore, we refer to
these chromosomally encoded FolP proteins containing the
signature Sul motif as FolP∗, and to their encoding gene
as folP∗.
In order to gain further insight into the possible chromosomal
origins of sul genes, we performed tBLASTX searches against the
NCBI RefSeq Genome Database (RefSeq, RRID:SCR_003496)
using the genetic surroundings (5,000 bp) of sul1, sul2, and
sul3 genes with at most 90% similarity to those reported in the
literature (Supplementary Table S3). This search did not return
consistent results for the sul1 and sul3 genetic surroundings,
but it identified a conserved gene fragment encoding the
N-terminal region of the phosphoglucosamine mutase GlmM
protein downstream of sul2 in multiple plasmids harboring
this resistance gene. These sul2-associated GlmM sequences
lack the entire GlmM C-terminal region, including three of
its functional domains (Mehra-Chaudhary et al., 2011), and it
can therefore be safely assumed that they are not functional as
phosphoglucosamine mutases. This genetic arrangement has
been reported previously as a feature of sul2 isolates (Kehrenberg
and Schwarz, 2005; Hu et al., 2016), and it is strongly conserved
in the genomic surroundings of chromosomal folP genes
in the Gammaproteobacteria, the Betaproteobacteria and
several Alphaproteobacteria lineages (Figure 1C). Analysis
of the folP genetic surroundings in complete genomes of
the Spirochaetes and the Alphaproteobacteria shows clear
differences between the genes coding for the identified
Rhodobiaceae and Leptospiraceae FolP∗ proteins harboring
the two-amino acid insertion pattern and those without it
(Figure 1C). The Leptospiraceae show a conserved arrangement
with folP∗ flanked by a peptidoglycan-associated lipoprotein
and a tetratricopeptide repeat-containing domain protein,
whereas in most other Spirochaetes folP is flanked by a 1-
deoxy-D-xylulose-5-phosphate synthase and a diadenylate
cyclase. In contrast, the Alphaproteobacteria yield several
distinct syntenic regions for folP. In the Rhodobiaceae,
folP∗ is flanked by genes coding for either a FtsH-family
metallopeptidase or a TetR-family transcriptional repressor and
the phosphoglucosamine mutase glmM. In the Rhodobacterales,
folP is flanked by a dihydroneopterin aldolase and glmM, but in
the Rhizobiales it is flanked by a Zn-dependent protease and the
dihydroneopterin aldolase. This last arrangement, in which the
dihydroneopterin aldolase is followed by a 2-amino-4-hydroxy-
6-hydroxymethyldihydropteridine diphosphokinase is also part
of the genetic surroundings of folP in most Actinobacteria
(Figure 1C).
Phylogenetic Analysis of sul/folP and
glmM Genes
The presence of a signature two-amino acid insertion
characteristic of sul gene products in chromosomally encoded
FolP∗ proteins and the identification of a genetic environment
for sul2 genes that is conserved in multiple bacterial genomes
suggested that it might be possible to pinpoint the evolutionary
origin of sul genes. To further investigate this possibility,
we performed a rigorous phylogenetic analysis of FolP/Sul
protein sequences. We sampled a representative genome of
all bacterial orders with complete genome assemblies, of each
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FIGURE 1 | (A) Segment of the multiple sequence alignment including any sul genes with at most 90% similarity to reported sul genes and a representative
chromosomal folP gene for all bacterial phyla with complete genomes available in NCBI RefSeq. (B) IceLOGO highlighting the difference in amino acid frequency at
each position of the region of the folP protein sequence containing the identified insertion between the multiple sequence alignment of sul gene products and the
chromosomally encoded FolP proteins. The upper part of the iceLOGO plot shows residues overrepresented in the sul-encoded FolP proteins; the bottom part
shows residues overrepresented in chromosomally encoded FolP proteins for all bacterial phyla with complete genomes available. Only differences with significant
z-score under a confidence interval of 0.01 are shown. (C) Schematic representation of the genetic environment of sul2 genes, similar arrangements in
chromosomally encoded folP genes of the Gammaproteobacteria, Betaproteobacteria, and Alphaproteobacteria, and arrangements in other major phyla. Arrow
boxes indicate coding regions. When available, gene names or NOG identifiers are provided. Boxes for folP genes containing the two-amino acid insertion are
designated as folP∗.
bacterial family for the Proteobacteria and all available complete
genomes for clades of interest (Rhodobiaceae, Spirochaetes, and
Chlamydiae), and we identified chromosomally encoded FolP
homologs in each of these genomes using BLASTP (BLASTP,
RRID:SCR_001010) with the E. coli FolP protein as a query. We
used a distance tree generated with CLUSTALW (Clustal Omega,
RRID:SCR_001591) to identify and discard a set of protein
sequences from duplicated folP genes in the Actinobacteria
(Supplementary Data 4), and we performed multiple sequence
alignment and Bayesian phylogenetic reconstruction of the
remaining FolP/Sul sequences with T-COFFEE (T-Coffee,
RRID:SCR_011818) and MrBayes (MrBayes, RRID:SCR_012067)
(Supplementary Data 5).
The resulting tree (Figure 2) provides strong support for
the hypothesis that sul1-3 genes originated in the Rhodobiaceae
and Leptospiraceae families. In particular, the topology inferred
by MrBayes suggests that the Leptospiraceae folP∗ gene gave
rise to both sul3 and the folP∗ gene encountered in the
Rhodobiaceae, most likely through a lateral gene transfer event
in an ancestor of this Alphaproteobacteria family. According to
the reconstructed FolP phylogeny, the Rhodobiaceae folP∗ gene
was subsequently mobilized as sul2, and later evolved into the
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FIGURE 2 | Consensus tree of Sul/FolP protein sequences. Branch support values are provided as Bayesian posterior probabilities. For clarity, only posterior
probability values higher than 0.8 are displayed. Proposed lateral gene transfer and mobilization events are shown by means of superimposed continuous and
dotted, respectively, arrows.
integron-borne sul1 gene (Orman et al., 2002). The fact that the
Leptospiraceae FolP∗ sequences branch independently of other
Spirochaetes sequences and immediately after the Chlamydiae
suggests that the Leptospiraceae folP∗ gene might have originated
as a result of lateral gene transfer event from the Chlamydiae,
and that it subsequently incorporated the signature two-amino
acid insert present in sul-encoded DHPS proteins. Importantly,
the trimmed multiple sequence alignment used for FolP/Sul
Bayesian phylogenetic inference (Supplementary Data 5) does
not incorporate the two-amino acid insertion of the Sul motif,
indicating that the joint branching of Sul1-3 sequences with
chromosomally encoded Rhodobiaceae and Leptospiraceae FolP
proteins is based on sequence similarity beyond this insertion and
its immediate vicinity (Figures 1A,B).
The existence of a genetic environment for sul2 genes
conserved in bacterial chromosomes provides the means to
independently assess the likelihood of the evolutionary scenario
inferred from the FolP phylogeny. Using the same sampling
methods utilized for sul/folP protein products, we collected
protein sequences for phosphoglucosamine mutase (GlmM)
homologs and performed Bayesian phylogenetic inference on the
aligned N-terminal regions. The resulting GlmM tree (Figure 3)
provides further support for a Rhodobiaceae origin of the
sul2 gene, with the sul2-associated GlmM sequences branching
with the Rhodobiaceae GlmM protein sequences deep within
an otherwise monophyletic Alphaproteobacteria clade. Taken
together, the consistent branching with the Rhodobiaceae of the
protein sequences encoded by both sul2 and its accompanying
glmM gene fragment firmly establish this Alphaproteobacteria
family as the chromosomal origin for the sul2 gene. The
phylogenetic evidence thus indicates that the sul2 gene was
excised with the N-terminal fragment of the glmM gene during
the mobilization event that led to their incorporation into
plasmid vectors. Given that the folP-glmM arrangement is only
seen in the Proteobacteria, this also excludes the possibility
that the sul2 gene was mobilized directly from a Leptospiraceae
background, where the folP gene presents an unrelated, yet
conserved, genomic environment (Figure 1C).
Analysis of sul/folP and glmM Gene
Sequences
The phylogenetic analysis of FolP and GlmM sequences puts
forward an evolutionary scenario wherein the Leptospiraceae
folP∗ was transferred to the members of the Rhodobiaceae
family before being mobilized independently into the sul3-
and sul1/2-harboring mobile genetic elements reported in
sulfonamide-resistant clinical isolates. To further investigate this
hypothesis, we undertook a systematic analysis of folP and
glmM coding sequences. We compiled folP gene sequences
for all the FolP proteins included in the phylogenetic analysis
(Figure 2), as well as any sul gene sequences with less
than 90% identity to those reported in the literature and
any chromosomal folP∗ genes encoding a DHPS with the
signature Sul motif (Figure 1A) for which there were at least
1 Mbp of whole genome shotgun sequence data (Supplementary
Data 6). We computed the overall and codon-position %GC
content on both the folP/sul coding sequences and all the
available coding sequences in their respective genome assembly
(Supplementary Table S4). The %GC content data (Figure 4A)
Frontiers in Microbiology | www.frontiersin.org 6 January 2019 | Volume 9 | Article 3332
fmicb-09-03332 January 5, 2019 Time: 18:24 # 7
Sánchez-Osuna et al. Origin of Clinical Sulfonamide Resistance
FIGURE 3 | Consensus tree of N-terminal GlmM protein sequences. Branch support values are provided as Bayesian posterior probabilities. For clarity, only
posterior probability values higher than 0.8 are displayed. The placement of sul2-encoded proteins is indicated by a shaded ellipse.
reveals that sul1/2 sequences have a high %GC content
(60.76 SD ± 1.42) that is consistent with their origin as
mobilized Rhodobiaceae folP∗ sequences (%GC content: 62.02
SD ± 2.22). Similarly, sul3 sequences display a %GC content
(38.14 SD ± 0.55) consistent with their mobilization from
a Leptospiraceae folP∗ background (39.39 SD ± 4.17). This
similarity in %GC content precludes the dating of these
mobilization events through analysis of DNA amelioration
rates. However, examination of DNA sequence similarity
(Table 1) reveals identity values of 50–60% between the
posited chromosomal donors and their mobile counterparts.
These values are in the lower range of sequence identities
for previously described mobilization events (Table 1), and
hence point to an early mobilization of folP∗ genes that is
consistent with the almost universal association of sul genes
with class 1 mobile integrons (Lévesque et al., 1995). Together
with the phylogenetic inference results, these data provide strong
support for an independent mobilization of sul1/2 and sul3
genes from, respectively, Rhodobiaceae and Leptospiraceae family
chromosomal backgrounds.
The independent mobilization of sul1/2 and sul3 is
underpinned by a preceding lateral gene transfer of folP∗
from the Leptospiraceae into a Rhodobiaceae ancestor. In this
context, the substantial divergence in %GC content between the
chromosomal folP∗ genes of both clades indicates a long process
of amelioration. In fact, statistical analysis of the differences
in codon position %GC content between folP genes and all
available coding sequences in their respective genomes shows
that Leptospiraceae and Rhodobiaceae folP∗ genes encoding
proteins with the Sul motif cannot be distinguished from other
folP genes (one-sided Mann–Whitney U-test p > 0.05 for GC1,
GC2, and GC3) (Figure 4B) (Supplementary Table S4). We used
Ameliorator (Lawrence and Ochman, 1997) to estimate the time
required for the observed amelioration via forward simulation
from Leptospiraceae codon position %GC values. Even under
assumptions of fast evolutionary change, the software provides a
lower bound of 476 million years for the observed amelioration
of the Leptospiraceae folP∗ gene into the Rhodobiaceae one.
Statistical analysis of synonymous and non-synonymous
mutation patterns in the N- and C-terminal regions of the
glmM gene also shows that mutation patterns in each region
of the Rhodobiaceae glmM gene are indistinguishable from
those observed in other glmM genes (one-sided Mann–Whitney
U-test p > 0.05). Since the glmM gene fragment associated to
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FIGURE 4 | (A) %GC content of folP and all other chromosomal coding sequences in different clades. The %GC content of sul1/2 and sul3 genes is shown adjacent
to that of the Rhodobiaceae and the Leptospiraceae. (B) Correlation between the %GC content of folP genes and that of all other coding sequences in their
respective genomes. The data points corresponding to folP∗ genes from the Rhodobiaceae and the Leptospiraceae are shown as squares.
sul2 genes is likely to be non-functional and subject to genetic
drift, the absence of diverging substitution patterns between the
N- and C-terminal regions of Rhodobiaceae glmM sequences
indicates that the glmM and sul2 genes were transferred from
the Rhodobiaceae to sul2-harboring vectors, and not vice versa
(Supplementary Table S5). Lastly, given that gene loss is much
more likely than gain (Kannan et al., 2013), the absence of glmM
fragments in sul1 isolates supports in turn the notion that sul1
derived from sul2. This is consistent with the branching pattern
observed in the FolP/Sul tree (Figure 2) and the observed DNA
identity values (Table 1), which define a scenario of independent
mobilization of sul3 from the Leptospiraceae and sul2 from the
Rhodobiaceae, with the subsequent uptake of sul1 by class 1
integrons.
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TABLE 1 | Percent GC content and nucleotide identity between posited chromosomal donors and the corresponding mobilized resistance genes for a number of
antibiotics.
Putative donor %GC Mobile determinant %GC % Identity PMID
Sulfonamide Leptospira interrogans 32.62 Salmonella enterica sul3 (WP_117344859.1) 37.75 51.91 (This work)
Leptospiraceae 39.39 ± 4.17 sul3 group 38.14 ± 0.55 49.73 ± 1.55 (This work)
Spirochaetales 52.22 ± 9.24 sul3 group 38.14 ± 0.55 47.28 ± 2.63 (This work)
Parvibaculum lavamentivorans 64.48 Pasteurella multocida sul2 (WP_010890206.1) 60.61 63.33 (This work)
Rhodobiaceae 62.02 ± 2.22 sul2 group 59.6 ± 2.70 60.46 ± 2.37 (This work)
Alphaproteobacteria 62.34 ± 13.20 sul2 group 59.6 ± 2.70 48.14 ± 3.28 (This work)
Parvibaculum lavamentivorans 64.48 Acinetobacter baumannii sul1 (AFB76381.1) 61.78 54.65 (This work)
Rhodobiaceae 62.02 ± 2.22 sul1 group 61.72 ± 0.09 54.06 ± 0.51 (This work)
Alphaproteobacteria 62.34 ± 13.20 sul1 group 61.72 ± 0.10 46.50 ± 3.48 (This work)
Vancomycin Amycolatopsis orientalis 64.86 vanX 64.59 76.57 22303296
Quinolones Shewanella algae 53.12 qnrA 53.27 95.6 16048974
Vibrio splendidus 44.44 qnrS 43.99 72.78 17452482
β-lactams Kluyvera cryocrescens 54.02 CTX-M-1 54.11 99.3 11709346
Kluyvera ascorbata 56.62 CTX-M-2 56.73 99.2 12183268
Kluyvera georgiana 57.07 CTX-M-8 57.08 98.5 12435721
Kluyvera georgiana 57.64 CTX-M-9 60.5 99 15855541
Kluyvera georgiana 57.53 CTX-M-25 57.99 95.9 20421403
Groups of homologs for sul genes correspond to sequences with at most 90% similarity to reported sul genes. For each donor clade and target group, the most likely
mapping is shown. Where appropriate, the PudMed identifier (PMID) for the reference establishing the correspondence between putative chromosomal donor and mobile
resistance determinant is provided.
Sulfonamide Resistance of
Chromosomal folP Genes
Phylogenetic and sequence analysis results indicate that
chromosomal folP∗ genes encoding proteins with the signature
Sul motif were independently mobilized into the sul1-3-
harboring mobile elements found in sulfonamide-resistant
clinical isolates, but they do not address whether the presence
of this motif is associated with sulfonamide resistance. To
investigate this possibility, we cloned the folP gene coding
for DHPS in the Rhodobiaceae P. lavamentivorans DS-1
(WP_012111048), the Leptospiraceae L. interrogans serovar
Lai str. 56601 (WP_000444207), the Rhodobacteraceae
R. sphaeroides 2.4.1 (WP_011337038) and the Chlamydiae
C. trachomatis D/UW-3/CX (WP_009871981). Following
Clinical and Laboratory Standards Institute (CLSI) guidelines
(Clinical and Laboratory Standards Institute, 2003), we then
performed broth microdilution assays to determine the minimal
inhibitory concentration (MIC) of sulfamethoxazole. The results
shown in Table 2 reveal that both P. lavamentivorans and
L. interrogans chromosomal folP∗ genes confer resistance to
sulfamethoxazole in an E. coli strain sensitive to sulfonamides.
These data are in agreement with previous reporting of
sulfonamide resistance in multiple L. interrogans strains
(Chakraborty et al., 2010, 2011; Wuthiekanun et al., 2015),
and suggest that the observed resistance was likely due
to mutations in the Leptospiraceae chromosomal folP∗
gene rather than to the presence of plasmid-borne sul
genes. Moreover, our results show that complementation
with folP genes from another Alphaproteobacteria family
lacking the Sul motif, the Rhodobacteraceae, does not confer
resistance to sulfamethoxazole. These results reveal that the
chromosomal folP∗ genes that gave rise to sul genes are capable
of conferring resistance to sulfonamide in E. coli. In contrast
with the Leptospiraceae and the Rhodobiaceae folP∗ genes, the
chromosomal folKP gene of the Chlamydiae, which encodes
a DHPS lacking the Sul motif, does not confer resistance to
sulfamethoxazole (Table 2). This is in agreement with abundant
reports of sulfonamide susceptibility in several Chlamydia
species (Hammerschlag, 1982; Fan et al., 1992; Sandoz and
Rockey, 2010; Marti et al., 2018). Since the Chlamydiae folKP
gene is the most closely related chromosomal folP gene to the
cluster encompassing the sul genes and the Leptospiraceae and
the Rhodobiaceae folP∗ (Figure 2), the lack of resistance in
Chlamydiae folKP genes strongly suggests that changes in the
region encompassing the Sul motif may be responsible for the
observed resistance. This region is located in a connector loop
within the N-terminal ‘pole’ of the eight-stranded α/β barrel of
DHPS, which is involved in sulfonamide recognition (Rådström
and Swedberg, 1988; Morgan et al., 2011). The two-amino acid
insertion might hence result in decreased affinity for sulfonamide
by locally disrupting folding, as has been proposed previously
for similar insertions in chromosomal folP genes (Achari et al.,
1997).
DISCUSSION
Prevalence of Sulfonamide Resistance in
Ancestral Bacteria
The evidence presented here converges toward an evolutionary
scenario in which sul1-3 genes from clinical isolates derive
from ancestral chromosomal mutations in the folP∗ gene of the
Leptospiraceae and the Rhodobiaceae (Figure 5). The emergence
and maintenance of a sulfonamide-resistant folP∗ gene in the
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TABLE 2 | Broth microdilution assays.
Sulfamethoxazole (mg/L)
Escherichia coli CGSC5073 8
Escherichia coli CGSC5073 pUA1108 8
Escherichia coli CGSC5073 pUA1108::folPPl >512
Escherichia coli CGSC5073 pUA1108::folPLi 512
Escherichia coli CGSC5073 pUA1108::folKPCt 4
Escherichia coli CGSC5073 pUA1108::folPRs 8
Escherichia coli CGSC5073 pUA1108::sul2 >512
Minimum inhibitory concentrations (MICs) of sulfamethoxazole in wild-type
Escherichia coli CGSC5073 carrying different versions of pUA1108::folP;
Pl, Parvibaculum lavamentivorans; Li, Leptospira interrogans; Ct, Chlamydia
trachomatis; Rs, Rhodobacter sphaeroides.
Leptospiraceae and its subsequent transfer to the Rhodobiaceae
suggests that it might have conveyed some selective advantage
prior to the introduction of sulfonamides, but the advent of
mutations providing significant resistance to sulfonamide and
their subsequent spread could also have been fortuitous. In both
scenarios, formally variants of an evolutionary exaptation process
(Gould and Vrba, 1982), a resistance-causing mutation may arise
and be maintained in the population in the absence of direct
antibiotic selection. Upon the clinical introduction of the relevant
antibiotic, selection favors the rapid spread of the resistance
determinant.
The emergence and maintenance of resistance against
synthetic chemotherapeutic agents prior to their clinical
deployment may hence reside in the evolution of resistance
as a side-effect of mutations providing some other fitness
benefit. A case in point is the evolution and rapid mobilization
via plasmid-borne qnr genes of resistance to quinolones
(Nordmann and Poirel, 2005). Qnr proteins bind to DNA
gyrase, the target of quinolones, early in the gyrase catalytic
cycle and decrease binding of quinolones to the enzyme-
DNA complex (Tran et al., 2005). Other members of the
pentapeptide repeat family are known to bind DNA gyrase and
provide some level of quinolone resistance (Hegde et al., 2005).
Conversely, qnr-encoded proteins can provide cross-protection
against naturally occurring antibiotics and synthetic agents
targeting DNA gyrase (Hooper and Jacoby, 2016). The likely
chromosomal origins of qnrA and qnrS genes have been
traced to water-borne isolates of, respectively, Shewanella
algae and Vibrio splendidus (Cantón, 2009) (Table 1). It has
been hypothesized that these ancestral qnr genes and other
pentapeptide repeat family members may have evolved to provide
resistance against other compounds targeting DNA gyrase, such
as the plasmid-borne microcin B17 (Heddle et al., 2001), as
elements facilitating or modulating the normal function of
DNA gyrase (Aminov and Mackie, 2007) or as functional
components of the adaptation of Shewanella species to cold
environments (Kim et al., 2011). In this context, the sequence
determinants associated with chromosomal folP∗ genes may have
originally enhanced PABA binding or another aspect of folate
biosynthesis (Sköld, 2000), provided protection against hitherto
unknown antibiotics targeting DHPS, or fulfilled an unrelated
function.
The emergence and persistence of mutations conferring
resistance against chemotherapeutic agents prior to their
discovery may also have taken place in the absence of selection
for the resistance-conferring mutations. The appearance of
sulfonamide-resistance mutations in chromosomal folP genes
has been amply documented (Huovinen et al., 1995; Sköld,
2000), and these were in fact the primary drivers of sulfonamide
resistance following the introduction of sulfa drugs (Sköld,
2000). Furthermore, it has been documented that the presence
of sulfonamide resistant DHPS does not necessarily impose a
fitness cost on bacteria (Enne et al., 2004). Structural studies
have suggested that most sulfonamide resistance mutations act
by modulating accessibility of sulfonamides to the PABA-binding
pocket without hindering PABA binding (Baca et al., 2000;
Morgan et al., 2011). It is hence conceivable that naturally
occurring mutations conferring resistance to sulfonamide might
not be selected against in the absence of this chemotherapeutic
agent. Subsequent complementary changes to adjust the affinity
for PABA of the altered DHPS molecule may have resulted
in fixation of the original mutations conferring resistance to
sulfonamide (Andersson, 2006).
Alternatively, sulfonamide resistance mutations in folP may
have arisen and persisted in response to naturally occurring
sulfonamides produced by competing organisms. Sulfonamides
are rare in nature, with only eight known natural sulfonamides
reported to date (Petkowski et al., 2018). Of these, only
two naturally occurring sulfonamides are aryl sulfonamides,
produced in very small amounts by recombinant Streptomyces
species harboring the complete xiamycin biosynthesis gene
cluster (Baunach et al., 2015). Although these sulfonamides show
potent antimicrobial activity, their bulky substitution pattern
suggests that their mode of action and molecular target are
likely different from synthetic aryl sulfonamides (Baunach et al.,
2015).
Mobilization of Ancestral Resistance
Reservoirs
The phylogenetic inference and genomic analysis results
reported in this work uphold an evolutionary scenario wherein
chromosomally encoded sulfonamide resistant folP variants were
independently mobilized from Leptospiraceae and Rhodobiaceae
backgrounds, and that mobile folP∗ genes subsequently spread
very rapidly following the clinical introduction of synthetic aryl
sulfonamides, giving rise to the sul1/2 and sul3 genes routinely
detected in clinical isolates (Figure 5). The rapid mobilization
and dissemination of genes conferring resistance to antibiotic
and chemotherapeutic agents upon the clinical or agricultural
use of these compounds has been amply documented (Aminov
and Mackie, 2007; Stokes and Gillings, 2011). Mobilization and
spread may be mediated by plasmids encoding transposons and
integrons, as well as integrative and conjugative elements, mobile
pathogenicity islands and bacteriophages, but the common tenet
is that sustained exposure of bacterial populations to antibiotics
or chemotherapeutic agents induces a strong selective pressure
to elicit the mobilization of resistance determinants (Stokes and
Gillings, 2011).
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FIGURE 5 | Schematic diagram of the evolutionary process leading to the emergence of sul1/2- and sul3-harboring mobile genetic elements. (1) A set of mutagenic
events in the Leptospiraceae folP gene generates the signature motif observed in folP∗ and sul genes. (2) Following the diversification of the Alphaproteobacteria, the
Leptospiraceae folP∗ gene is transferred to the Rhodobiaceae. (3) Upon the clinical and agricultural introduction of sulfonamides, folP∗ genes from the
Leptospiraceae and the Rhodobiaceae are independently mobilized, giving rise to the sul–containing mobile elements reported in clinical isolates. This figure was
constructed using some Servier Medical Art templates, which are licensed under a Creative Commons - Attribution Unported License.
Together with penicillin and tetracycline, sulfonamides
have been the antibacterial agents most frequently used
at sub-therapeutic levels in livestock production (Franco
et al., 1990), and it has been reported that sulfonamides
have higher mobility, lower removal efficiency and deeper
environmental penetration than most other antibacterial agents
(Kumar et al., 2005). The widespread and intensive use of
sulfonamides in agriculture, aquaculture and animal husbandry
since the mid 1960’s, and their persistence in soil, sediments
and subterranean aquatic communities where Leptospiraceae
and Rhodobiaceae abound, provides an ample window of
opportunity for the spread of chromosomally encoded or already
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mobilized folP∗ genes within these bacterial communities and the
subsequent transfer of these mobile resistance determinants to
other bacterial clades.
Recent mobilization from a Chloroflexi chromosomal folP
background has been postulated as the likely origin of the sul4
gene (Razavi et al., 2017), and this result is in agreement with the
phylogenetic analysis reported here (Figure 2). In the case of the
chromosomal folP∗ genes identified here and their mobilization
into sul-harboring resistance vectors, several sources of evidence
provide additional support for the frequent mobilization of
chromosomal folP genes. For instance, phylogenetic evidence
(Figure 2) indicates that the Rhodobiaceae folP∗ was incorporated
at some point by the Actinobacterium Amycolatopsis, which
harbors three folP orthologs (Supplementary Data 7). Similarly,
a plasmid broadly distributed among Azospirillum isolates
(e.g., AP010951, FQ311873), a member of the Rhodospirillaceae
Alphaproteobacteria family, contains a folP gene flanked by genes
coding for a flagellar export pore protein (FlhB) and the full
length phosphoglucosamine mutase (GlmM) (Supplementary
Data 7). This folP does not contain the signature two-amino acid
insertion, indicating that its mobilization occurred independently
of those leading to sul1/2 genes.
More significantly, a partial genomic sequence from a
Pseudomonas aeruginosa isolate (LLMY01000073.1) harbors a
folP∗ gene with high sequence and genetic neighborhood
similarity to the Rhodobiaceae P. lavamentivorans DS-1 (van
Belkum et al., 2015). The genes immediately upstream and
downstream of this P. aeruginosa folP∗, which contains the
Sul motif, encode a TetR family regulator and a partial
phosphoglucosamine mutase (GlmM) protein (Supplementary
Data 7). These three genes are flanked by IS91 and ISL3 family
transposases. Importantly, the IS91 transposase contains similar
sequence motifs and shares termini identity with ISCR elements,
which are present in both sul1 and sul2-harboring plasmids
(Toleman et al., 2006; Toleman and Walsh, 2011). Moreover,
this P. aeruginosa folP∗ presents 72.76% nucleotide identity with
the P. lavamentivorans folP∗, which is significantly higher than
the one observed between P. lavamentivorans folP∗ and sul2
(Table 1). It is hence highly likely that the P. aeruginosa folP∗
represents an intermediate step or an independent mobilization
of the Rhodobiaceae folP∗.
Taken together, the protein sequence phylogeny and genomic
context evidence (Figures 1–3), the absence of Sul-containing
motifs in any other chromosomal folP genes (Figure 1), the tight
alignment in %GC content between the different chromosomal
folP∗ and mobile sul genes (Figure 4), and the identification of
multiple folP mobilization events consistently point toward an
independent mobilization from Leptospiraceae and Rhodobiaceae
chromosomal backgrounds that gave rise to, respectively, sul3
and sul2/1 genes. The close similarity in %GC content between
the putative donor and mobilized sequences (Figure 4), and
the lack of suitable models for sequence evolution in mobile
elements make it difficult to estimate precisely the timing of
this mobilization using sequence analysis methods. The relatively
low nucleotide sequence identity between the Leptospiraceae and
Rhodobiaceae chromosomal folP∗ genes and sul genes (Table 1)
suggests that folP∗ genes were mobilized and diversified long
before the clinical introduction of sulfonamides. Nonetheless,
extensive recombination and unusual selection pressures on
mobile elements could in principle also account for the observed
sequence divergence within a shorter timescale. What seems
abundantly clear is that shortly after the clinical introduction of
sulfonamides, sul genes spread rapidly on a variety of mobile
elements, as attested by the well-established association between
sul genes and integrons (Lévesque et al., 1995; Davies, 2007).
Metagenomics analysis and prospective studies of preserved
ancient environments, such as permafrost and remote cave
habitats, have largely displaced the notion that antibiotic
resistance emerges in response to anthropogenic antibiotic use
(D’Costa et al., 2011; Bhullar et al., 2012; Perron et al., 2015;
Crofts et al., 2017). These studies have conclusively shown that
antibiotic resistance predates the use of antibiotics by humans,
and that it is widely distributed across the bacterial pangenome.
In a few isolated cases, resistance determinants for synthetic
chemotherapeutic agents that predate or have rapidly arisen upon
human use has been documented, but their existence can be
attributed to cross-resistance to naturally occurring antibiotics
[e.g., microcin B17 for quinolones (Tran and Jacoby, 2002),
sisomicin for amikacin (Perron et al., 2015)]. The identification
in this work of ancient chromosomal mutations in folP conferring
resistance to sulfonamide as the likely origins of the sul1-3 genes
present in sulfonamide-resistant clinical isolates puts forward
an alternative scenario. Given the absence of known naturally
occurring aryl sulfonamides targeting DHPS, our results suggest
that resistance to novel synthetic chemotherapeutic agents may
be already available in the vast microbial pangenome, and that
its global dissemination can take place in a very short amount
of time upon the clinical introduction of novel chemotherapeutic
compounds.
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